Alain Kaelin

🇨🇭Switzerland
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Technical and Clinical Validation of the WPM-SEMG Prototype

Not Applicable
Recruiting
Conditions
Neuron Disease, Motor
Interventions
Device: WPM-SEMG prototype
First Posted Date
2024-09-04
Last Posted Date
2024-09-04
Lead Sponsor
Alain Kaelin
Target Recruit Count
70
Registration Number
NCT06584084
Locations
🇨🇭

Neurocentro della Svizzera Italiana, Lugano, Switzerland

Clinical Relevance of the HD sEMG Signals in the Post-stroke Rehabilitation

Not Applicable
Recruiting
Conditions
Stroke
Interventions
Device: Acquisition of HD sEMG signals using the WPM-SEMG device
First Posted Date
2023-05-09
Last Posted Date
2024-01-16
Lead Sponsor
Alain Kaelin
Target Recruit Count
40
Registration Number
NCT05849896
Locations
🇨🇭

Istituto di Neuroscienze Cliniche della Svizzera Italiana, Lugano, Switzerland

IncobotulinumtoxinA (Xeomin) to Treat Focal Hand Dystonia

Phase 3
Recruiting
Conditions
Focal Hand Dystonia
Interventions
Drug: Placebo - Concentrate
Drug: Xeomin
First Posted Date
2019-06-06
Last Posted Date
2024-03-15
Lead Sponsor
Alain Kaelin
Target Recruit Count
48
Registration Number
NCT03977493
Locations
🇨🇭

Inselspital - University Hospital Berne, Berne, Switzerland

🇨🇭

USZ- Univerity Hospital Zurich, Zurich, Switzerland

🇨🇭

Neurocentro della Svizzera Italiana, Lugano, Switzerland

and more 2 locations

Effect of Safinamide on Sleep Quality in Patients With Parkinson's Disease

First Posted Date
2019-05-30
Last Posted Date
2024-03-15
Lead Sponsor
Alain Kaelin
Target Recruit Count
23
Registration Number
NCT03968744
Locations
🇨🇭

Neurocenter of Southern Switzerland - Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy